Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03539874Unknown

Sperm Oxidative Stress and Pregnancy Success During IUI and IVF

Role: lead

NCT04937608Terminated

Impact of the Coronavirus Disease 2019 (COVID-19) on Sperm Parameters

Role: lead

NCT04753736Not ApplicableWithdrawn

Immunophenotypage of RIF and RM Patients and Intrauterine Administration of PBMC

Role: lead

NCT04648566Not ApplicableCompleted

Endometrium Immunomodulation by in Utero Administration of Peripheral Blood Mononuclear Cells

Role: lead

All 4 trials loaded